• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期类风湿关节炎的奈梅亨起始队列研究。

The Nijmegen inception cohort of early rheumatoid arthritis.

作者信息

Welsing Paco M J, van Riel Piet L C M

机构信息

Department of Rheumatology, University Medical Centre Nijmegen, Nijmegen, The Netherlands.

出版信息

J Rheumatol Suppl. 2004 Mar;69:14-21.

PMID:15053447
Abstract

Rheumatoid arthritis is a heterogeneous chronic disease with an unpredictable disease course. To study such a disease, longterm observational studies are needed, with regular assessment of patients using valid and reproducible measures. This article describes the purpose and design of such a study at the Department of Rheumatology, University Medical Centre Nijmegen. Within this inception cohort, several instruments to assess RA were developed and validated, such as the Disease Activity Score, the European League Against Rheumatism response criteria, and a Dutch version of the Health Assessment Questionnaire disability index. These instruments are described and results of studies are discussed concerning prognostic and predictive factors, disease course, and the relationship between the different process and outcome measures.

摘要

类风湿性关节炎是一种具有不可预测病程的异质性慢性疾病。为研究此类疾病,需要进行长期观察性研究,并使用有效且可重复的方法对患者进行定期评估。本文描述了奈梅亨大学医学中心风湿病科开展的此类研究的目的和设计。在这个初始队列中,开发并验证了多种评估类风湿性关节炎的工具,如疾病活动评分、欧洲抗风湿病联盟反应标准以及荷兰版健康评估问卷残疾指数。本文介绍了这些工具,并讨论了关于预后和预测因素、疾病病程以及不同过程和结果指标之间关系的研究结果。

相似文献

1
The Nijmegen inception cohort of early rheumatoid arthritis.早期类风湿关节炎的奈梅亨起始队列研究。
J Rheumatol Suppl. 2004 Mar;69:14-21.
2
Is the disease course of rheumatoid arthritis becoming milder? Time trends since 1985 in an inception cohort of early rheumatoid arthritis.类风湿关节炎的病程是否正变得更轻微?1985年以来早期类风湿关节炎起始队列中的时间趋势。
Arthritis Rheum. 2005 Sep;52(9):2616-24. doi: 10.1002/art.21259.
3
Performance of a rheumatoid arthritis records-based index of severity.基于类风湿性关节炎记录的严重程度指数的性能。
J Rheumatol. 2005 Sep;32(9):1679-87.
4
Established rheumatoid arthritis: clinical assessments.确诊的类风湿性关节炎:临床评估
Best Pract Res Clin Rheumatol. 2007 Oct;21(5):807-25. doi: 10.1016/j.berh.2007.06.001.
5
The LUNDEX, a new index of drug efficacy in clinical practice: results of a five-year observational study of treatment with infliximab and etanercept among rheumatoid arthritis patients in southern Sweden.LUNDEX,一种临床实践中药物疗效的新指标:瑞典南部类风湿关节炎患者使用英夫利昔单抗和依那西普治疗的五年观察性研究结果
Arthritis Rheum. 2006 Feb;54(2):600-6. doi: 10.1002/art.21570.
6
Chronic comorbidity in patients with early rheumatoid arthritis: a descriptive study.
J Rheumatol. 2001 Jul;28(7):1511-7.
7
Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.类风湿关节炎患者中抗TNF-α治疗反应的预测因素:来自英国风湿病学会生物制剂登记处的结果
Rheumatology (Oxford). 2006 Dec;45(12):1558-65. doi: 10.1093/rheumatology/kel149. Epub 2006 May 16.
8
Predicting arthritis outcomes--what can be learned from the Leiden Early Arthritis Clinic?预测关节炎结局——莱顿早期关节炎诊所能带来哪些启示?
Rheumatology (Oxford). 2011 Jan;50(1):93-100. doi: 10.1093/rheumatology/keq230. Epub 2010 Jul 16.
9
Assessment of American College of Rheumatology quality criteria for rheumatoid arthritis in a pre-quality criteria patient cohort.对类风湿关节炎美国风湿病学会质量标准在质量标准出台前患者队列中的评估。
Arthritis Rheum. 2007 Jun 15;57(5):707-15. doi: 10.1002/art.22781.
10
Functional outcome and subset identification in RA patients from meridional Europe: analysis of a Spanish cohort.来自欧洲南部的类风湿关节炎患者的功能结局与亚组识别:西班牙队列分析
Clin Rheumatol. 2003 May;22(2):77-83. doi: 10.1007/s10067-002-0659-0.

引用本文的文献

1
Refractory inflammatory arthritis definition and model generated through patient and multi-disciplinary professional modified Delphi process.通过患者和多学科专业人员修改后的德尔菲流程生成的难治性炎症性关节炎定义和模型。
PLoS One. 2023 Aug 9;18(8):e0289760. doi: 10.1371/journal.pone.0289760. eCollection 2023.
2
Plasma metabolomic profiling in patients with rheumatoid arthritis identifies biochemical features predictive of quantitative disease activity.类风湿关节炎患者的血浆代谢组学分析鉴定出预测定量疾病活动的生化特征。
Arthritis Res Ther. 2021 Jun 8;23(1):164. doi: 10.1186/s13075-021-02537-4.
3
Predictors of health care drop-out in an inception cohort of patients with early onset rheumatoid arthritis.
早发型类风湿关节炎初始队列中医疗保健中断的预测因素。
BMC Musculoskelet Disord. 2017 Jul 28;18(1):321. doi: 10.1186/s12891-017-1670-6.
4
Serum anticyclic citrullinated protein antibody titers are correlated with the response to biological agents in patients with rheumatoid arthritis.类风湿关节炎患者血清抗环瓜氨酸化蛋白抗体滴度与对生物制剂的反应相关。
Open Access Rheumatol. 2014 May 16;6:57-64. doi: 10.2147/OARRR.S58772. eCollection 2014.
5
Cost-effectiveness of abatacept, rituximab, and TNFi treatment after previous failure with TNFi treatment in rheumatoid arthritis: a pragmatic multi-centre randomised trial.类风湿关节炎患者此前使用肿瘤坏死因子抑制剂(TNFi)治疗失败后,阿巴西普、利妥昔单抗及TNFi治疗的成本效益:一项实用多中心随机试验
Arthritis Res Ther. 2015 May 22;17(1):134. doi: 10.1186/s13075-015-0630-5.
6
Modelling outcomes of complex treatment strategies following a clinical guideline for treatment decisions in patients with rheumatoid arthritis.针对类风湿性关节炎患者治疗决策的临床指南,对复杂治疗策略的结果进行建模。
Pharmacoeconomics. 2014 Oct;32(10):1015-28. doi: 10.1007/s40273-014-0184-4.
7
Treating to the target of remission in early rheumatoid arthritis is cost-effective: results of the DREAM registry.早期类风湿关节炎达到缓解目标的治疗具有成本效益:DREAM 登记研究结果。
BMC Musculoskelet Disord. 2013 Dec 13;14:350. doi: 10.1186/1471-2474-14-350.
8
Meta-analysis identified the TNFA -308G > A promoter polymorphism as a risk factor for disease severity in patients with rheumatoid arthritis.荟萃分析确定肿瘤坏死因子α(TNFA)-308G>A启动子多态性是类风湿关节炎患者疾病严重程度的一个风险因素。
Arthritis Res Ther. 2012 Dec 7;14(6):R264. doi: 10.1186/ar4110.
9
Genetic variants in toll-like receptors are not associated with rheumatoid arthritis susceptibility or anti-tumour necrosis factor treatment outcome.TLR 基因多态性与类风湿关节炎易感性及抗 TNF 治疗应答无关。
PLoS One. 2010 Dec 15;5(12):e14326. doi: 10.1371/journal.pone.0014326.
10
Time to achieve remission determines time to be in remission.达到缓解的时间决定了处于缓解期的时间。
Arthritis Res Ther. 2010;12(3):R97. doi: 10.1186/ar3027. Epub 2010 May 20.